Japan approves first generic biotech drug
Tuesday, June 30, 2009 - 13:42
in Biology & Nature
ZURICH (Reuters) - Japanese regulators approved a human growth hormone from Novartis AG, the first green light in Japan for a biosimilar or generic version of a biotech drug, the Swiss drugmaker said on Thursday.